L Ramos-Ruperto, C Busca-Arenzana… - SN Comprehensive …, 2021 - Springer
Our case highlights SARS-CoV-2 and pembrolizumab as trigger of secondary hemophagocytic lymphohistiocytosis. Although it is a rare complication, it must be suspected …
DA Eichenauer, P La Rosée - Die Innere Medizin, 2023 - Springer
Die hämophagozytische Lymphohistiozytose (HLH) ist ein hyperferritinämisches Hyperinflammationssyndrom. Es wird eine hereditäre von einer erworbenen Form …
Severe COVID-19 patients present a clinical and laboratory overlap with other hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) …
Objective: To evaluate the effect of rectal Ozone (O3) in severe COVID-19 pneumonia in two different cohorts differing in location (Madrid vs Zilina), ethnicity (Slovakian vs Spanish …
F Hammami, M Koubaa, K Rekik… - Journal of Applied …, 2021 - journals.lww.com
The outbreak of the novel coronavirus-19 (COVID-19) rapidly grew into a worldwide pandemic. The link between the disease severity and higher levels of inflammatory markers …
AE Oppong, L Coelewij, M Hutchinson, B Carpenter… - papers.ssrn.com
Background: Dexamethasone is currently recommended for use in all patients with COVID- 19 requiring supplemental oxygen, however, only some patients develop hyperinflammation …
S Tanga, S Lia, S Zhenga, Y Dinga, D Zhua, C Sunb… - ku-55933inhibitor.com
Macrophage activation syndrome (MAS) is a potentially life-threatening complication of systemic autoin-flammatory/autoimmune diseases, generally systemic juvenile idiopathic …
S Tehrani, H Shabanpour Dehbaneh… - International Journal of …, 2022 - academia.edu
Background: Due to uncontrolled lymphocyte reaction, the overproduction of cytokines in COVID-19 patients can cause sepsis-like symptoms, suggesting sepsis, cytokine release …